JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v5i3.2454 jpsim.v5i3.2454 Original Research Frequency of Asymptomatic Spontaneous Bacterial Peritonitis in Patients of Chronic Liver Disease with Ascites Din Shams u shamsudin111@gmail.com * Irfan Hafiz Muhammad Yousaf Sadaf Riaz Muhammad Kazi Asma Rizwan Hafiz Muhammad Rasheed Anjum Mohsin Aftab Sir Ganga Ram Hospital, Lahore, Department of Medicine, Arif Memorial Teaching Hospital, Lahore, Chaudhry Muhammad Akram Teaching and Research Hospital, Lahore *Correspondence: Shams u Din (shamsudin111@gmail.com) 30 08 2024 2024 5 3 629 634 08 04 2024 07 08 2024 Copyright © 2024 The Author(s) 2024 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective

This research aimed to quantify the prevalence of asymptomatic spontaneous bacterial peritonitis in individuals with chronic liver disease and ascites.

 Methodology

The study was conducted in the department of Medicine, Arif memorial teaching hospital, Lahore. The study was carried out over 6 months’ period from 01-06-2022 to 30-11-2022. Total 174 patients of either gender with chronic liver disease with ascites were included in the study. Spontaneous bacterial peritonitis was defined as ascitic fluid examination consistent with Total white cell count > 500/mm3 or neutrophils > 250/mm3 and a positive culture (>105 colonies) in the absence of fever (temp. >99 F), abdominal pain and tenderness.

 Results

174 patients were included in our study population. Eight (4.6%) patients were aged 31-40 years, 68 (43.7%) were aged 40-50 years and 98 (56.3%) had age > 50 years. 58 patients (33.3%) were male and remaining 116 patients (66.7%) were female. 46 patients (26.4%) had spontaneous bacterial peritonitis

 Conclusion

Patients with chronic liver illness and ascites have a significant prevalence of asymptomatic spontaneous bacterial peritonitis, with our analysis putting the number at 26.4%.

 Keywords Spontaneous bacterial peritonitis Chronic liver disease Ascites References Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clinical Gastroenterology Hepatology. 2020;18(12):2650-66. Rostkowska K, Szymanek-Pasternak A, Simon K. Spontaneous bacterial peritonitis–therapeutic challenges in the era of increasing drug resistance of bacteria. Clinical experimental hepatology. 2018;4(4):224-31. Haque LY, Garcia‐Tsao G. A historical overview of spontaneous bacterial peritonitis: From rare to resistant. Clin Liver Dis. 2021;18(Suppl 1):63. Alotaibi A, Almaghrabi M, Ahmed O, Rodrigues D, Iansavichene A, Puka K, et al. Incidence of spontaneous bacterial peritonitis among asymptomatic cirrhosis patients undergoing outpatient paracentesis: A systematic review and meta-analysis. Eu J Gastroenterol Hepatol. 2021;33(1S):e851-e7. Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatol. 2016;64(4):1265-72. Tu B, Zhang Y-N, Bi J-F, Xu Z, Zhao P, Shi L, et al. Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis. World J Gastroenterol. 2020;26(29):4316. Shiani A, Narayanan S, Pena L, Friedman M. The role of diagnosis and treatment of underlying liver disease for the prognosis of primary liver cancer. Cancer Control. 2017;24(3):1073274817729240. Liu M, Tseng T-C, Jun DW, Yeh M-L, Trinh H, Wong GL, et al. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in asian chronic hepatitis b patients. Hepatol Int. 2021;15(1):71-81. Kumagai T, Terashima H, Uchida H, Fukuda A, Kasahara M, Kosuga M, et al. A case of niemann-pick disease type c with neonatal liver failure initially diagnosed as neonatal hemochromatosis. Brain Develop. 2019;41(5):460-4. Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by step: Managing the complications of cirrhosis. Hepatic Medicine: Evid Res. 2021;13(1):45. Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, et al. Myosteatosis in cirrhosis: A review of diagnosis, pathophysiological mechanisms and potential interventions. Cells. 2022;11(7):1216. Singal AG, Zhang E, Narasimman M, Rich NE, Waljee AK, Hoshida Y, et al. Hcc surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J Hepatol. 2022;77(1):128-39. Marquardt P, Liu PH, Immergluck J, Olivares J, Arroyo A, Rich NE, et al. Hepatocellular carcinoma screening process failures in patients with cirrhosis. Hepatol Commun. 2021;5(9):1481-9. Jiang Y, Zhang M, Zhu Y, Zhu D. Diagnostic role of contrast-enhanced ultrasonography versus conventional b-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: A retrospective study. J Gastroint Oncol. 2021;12(5):2403. Bartolotta TV, Randazzo A, Bruno E, Taibbi A. Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography. World J Radiol. 2022;14(4):70. Turon F, Driever EG, Baiges A, Cerda E, García-Criado Á, Gilabert R, et al. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors. Journal of hepatology. 2021;75(6):1367-76. Deng H, Qi X, Guo X. Computed tomography for the diagnosis of varices in liver cirrhosis: A systematic review and meta-analysis of observational studies. Postgrad Med. 2017;129(3):318-28. Nahon P, Najean M, Layese R, Zarca K, Segar LB, Cagnot C, et al. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis. JHEP Reports. 2022;4(1):100390. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, et al. Transplantation for hepatocellular carcinoma and cirrhosis: Sensitivity of magnetic resonance imaging. Liver Transplant. 2002;8(12):1156-64. Sridharan B, Devarajan N, Jobanputra R, Gowd GS, Anna IM, Ashokan A, et al. Ncp: Fe nanocontrast agent for magnetic resonance imaging-based early detection of liver cirrhosis and hepatocellular carcinoma. ACS Applied Bio Materials. 2021;4(4):3398-409. Cerrito L, Ainora ME, Nicoletti A, Garcovich M, Riccardi L, Pompili M, et al. Elastography as a predictor of liver cirrhosis complications after hepatitis c virus eradication in the era of direct-acting antivirals. World J Hepatol. 2021;13(11):1663. Chen S, Bao J. The value of nuclear magnetic resonance in liver nodular lesions. Contrast Media Mol Imag. 2022;2022. Eichholz JC, Kirstein MM, Book T, Wedemeyer H, Voigtländer T. Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis. Eu J Gastroenterol. Hepatology. 2021;33(12):1582-7. Biggins SW, Angeli P, Garcia‐Tsao G, Ginès P, Ling SC, Nadim MK, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases. Hepatol. 2021;74(2):1014-48. Pimentel R, Gregório C, Figueiredo P. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: Systematic review. Acta Gastro-Enterologica Belgica. 2021;84:333-42. Honar N, Nezamabadipour N, Dehghani SM, Haghighat M, Imanieh MH, Ataollahi M, et al. An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis. BMC Pediat. 2022;22(1):1-7. Popoiag R-E, Panaitescu E, Suceveanu A-I, Suceveanu A-P, Micu SI, Mazilu L, et al. Spontaneous bacterial peritonitis mortality trends of cirrhotic patients in the last decade in constanta county. Experi Therap Med. 2021;22(1):1-6. Ramadan HKA, Kamel SI, Rashed H-AG, Georgy AA, Ahmed AO. Antibiotic susceptibility of asymptomatic spontaneous bacterial peritonitis in decompensated liver cirrhosis: A prospective study. J Curr Med Res Practice. 2021;6(3):291. Mazzini FN, Cook F, Gounarides J, Marciano S, Haddad L, Tamaroff AJ, et al. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: Effect of pnpla3 genotype. Metabolomics. 2021;17(7):1-13. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review. J Hepatol. 2012;56(5):1181-8. Pervez MA, Khan DA, Slehria AUR, Ijaz A. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Complementary Therap Med. 2020;52:102494. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatol. 2003;37(4):897-901. Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis. World J Gastroenterol. 2009;15(44):5505.